Article
Correction of aberrant pre-mRNA splicing by antisense oligonucleotides in beta-thalassemia Egyptian patients with IVSI-110 mutation.
Journal of pediatric hematology/oncology - 1 Apr 2008
El-Beshlawy Amal, Mostafa Azza, Youssry Ilham, Gabr Hala, Mansour Iman M, El-Tablawy Manar, Aziz Mona, Hussein Ibtissam R
Abstract excerpt
The splicing mutation in intron 1 of beta-globin gene (IVS1-110) is the most common mutation in Egyptian thalassemics that causes aberrant splicing of pre-mRNA and deficient beta-globin chain synthesis. Antisense oligonucleotides (ASONs) are compounds that redirect pre-mRNA splicing and modify gene expression. Our aim was ex vivo correction of the aberrant splicing of beta-globin110 pre-mRNA by ASON against the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
